REFRAMINERALS
ActiveSummary
The computed 12-month bankruptcy probability of REFRAMINERALS is 1.6% (moderate). The annual accounts of REFRAMINERALS for financial year 2025 show a net loss of 102% of total assets and of 99% of the equity at the start of that year. The 2025 annual accounts show equity of €298 and a net result of -€27,043. Equity is shrinking by about 8.2% per year across the filed financial years. Its solvency ranks better than 20% of 13,576 sector peers (NACE 46, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Weakest financial yearnet -€27,043
Net result drops to -€27,043, the lowest in the series.
31-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Back to profitnet €503
Net result €503 after 2 loss-making years.
30-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
29-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
30-09
NBB filing
Annual accounts filed
financial year 2021 · micro format · 61 days late
2021
30-09
NBB filing
Annual accounts filed
financial year 2020 · micro format · 61 days late
2020
30-11
NBB filing
Annual accounts filed
financial year 2019 · micro format · 122 days late
2019
31-12
Financial
Back to profitnet €24,519
Net result €24,519 after one loss-making year.
31-12
Financial
Liquidity more than doubledcurrent ratio 3.91
Current ratio from 1.75 to 3.91; short-term debt falls from €24,055 to €11,724.
30-09
NBB filing
Annual accounts filed
financial year 2018 · micro format · 61 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.